Renal Function Outcomes in De Novo Kidney Transplant Recipients Receiving Everolimus with Reduced-Exposure Calcineurin Inhibitor versus Mycophenolate with Standard-Exposure Calcineurin Inhibitor: Results from the TRANSFORM Study

被引：1
|
作者：
Oppenheimer, Federico [1 ]
Russ, Graeme [2 ]
Viklicky, Ondrej [3 ]
Oberbauer, Rainer [4 ]
Garcia, Valter [5 ]
Witzke, Oliver [6 ]
Kuypers, Dirk [7 ]
Danguilan, Romina [8 ]
Das Gupta, Ayan [9 ]
Bernhardt, Peter [10 ]
Sommerer, Claudia [11 ]
机构：
[1] Hosp Clin Barcelona, Barcelona, Spain
[2] Royal Adelaide Hosp, Adelaide, SA, Australia
[3] IKEM, Prague, Czech Republic
[4] Med Univ Vienna, Vienna, Austria
[5] Santa Casa Misericordia Porto Alegre, Porto Alegre, RS, Brazil
[6] Univ Klinikum Essen, Essen, Germany
[7] Gasthuisberg Univ Hosp, Leuven, Belgium
[8] Natl Kidney & Transplant Inst, Quezon City, Philippines
[9] Novartis Healthcare Pvt Ltd, Hyderabad, India
[10] Novartis Pharma AG, Basel, Switzerland
[11] Univ Klinikum Heidelberg, Heidelberg, Germany
来源：
TRANSPLANTATION | 2018年 / 102卷
关键词：
D O I：
10.1097/01.tp.0000543112.91427.9d
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
591.2
引用
收藏
页码：S363 / S363
页数：1
相关论文
共 50 条
  • [41] TRANSFORM STUDY TO EVALUATE THE EFFECT OF EVEROLIMUS WITH REDUCED CALCINEURIN INHIBITORS IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: BASELINE DATA
    Arns, W.
    Weithofer, P.
    Witzke, O.
    Habicht, A.
    Banas, B.
    Renders, L.
    Rath, T.
    Lehner, F.
    Bartels, M.
    Von der Giet, M.
    Sommerer, C.
    TRANSPLANT INTERNATIONAL, 2015, 28 : 25 - 25
  • [42] EFFICACY, RENAL FUNCTION AND SAFETY OF EVEROLIMUS [EVR] WITH REDUCED-DOSE CALCINEURIN INHIBITOR [RCNI] IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS [KTXR]: M24 RESULTS
    Albano, L.
    Buchler, M.
    Pernin, V.
    Vuiblet, V.
    Bernhardt, P.
    Hernandez-Gutierrez, P.
    Capela, D.
    Gharbi, H.
    Legendre, C.
    TRANSPLANT INTERNATIONAL, 2020, 33 : 12 - 12
  • [43] EFFICACY AND SAFETY OF EVEROLIMUS WITH REDUCED-EXPOSURE CYCLOSPORINE IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: 24-MONTH ANALYSIS FROM THE TRANSFORM STUDY
    Sommerer, Claudia
    Pinchuk, Aleksey
    Aleman, Silvina
    Vuiblet, Vincent
    Van der Giet
    Amante, Angel Joaquin
    Han, Duck Jong
    Huynh-Do, Uyen
    Ingsathit, Atiporn
    Gawai, Apurva
    Gutierrez, Maria Pilar Hernandez
    Carmellini, Mario
    TRANSPLANTATION, 2020, 104 (09) : S622 - S623
  • [44] Everolimus-facilitated calcineurin inhibitor reduction in Asian de novo kidney transplant recipients: 2-year results from the subgroup analysis of the TRANSFORM study
    Watarai, Yoshihiko
    Danguilan, Romina
    Casasola, Concesa
    Chang, Shen-Shin
    Ruangkanchanasetr, Prajej
    Kee, Terence
    Wong, Hin Seng
    Kenmochi, Takashi
    Amante, Angel Joaquin
    Shu, Kuo-Hsiung
    Ingsathit, Atiporn
    Bernhardt, Peter
    Hernandez-Gutierrez, Maria Pilar
    Han, Duck Jong
    Kim, Myoung Soo
    CLINICAL TRANSPLANTATION, 2021, 35 (10)
  • [45] Analysis of Renal Function in Everolimus/Enteric-Coated Mycophenolate Sodium Treated De Novo Renal Transplant Recipients after Calcineurin Inhibitor Withdrawal: The ZEUS Study.
    Budde, K.
    Becker, T.
    Arns, W.
    Sommerer, C.
    Reinke, P.
    Eisenberger, U.
    Fischer, W.
    Kramer, S.
    Pietruck, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 259 - 259
  • [46] TRANSFORM: A NOVEL STUDY TO EVALUATE THE EFFECT OF EVEROLIMUS WITH REDUCED CALCINEURIN INHIBITORS IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: BASELINE DATA
    Pascual, Julio
    TRANSPLANT INTERNATIONAL, 2015, 28 : 442 - 442
  • [47] Effects of the De Novo use of Everolimus with Reduced Calcineurin Inhibitor on Wound Healing Events in the TRANSFORM Study
    Citterio, Franco
    Watarai, Yoshihiko
    Mulgaonkar, Shamkant
    Uyen Huynh-Do
    Bernhardt, Peter
    Henry, Mitchell
    TRANSPLANTATION, 2018, 102 : S94 - S94
  • [48] Everolimus and reduced calcineurin inhibitor therapy in pediatric liver transplant recipients: Results from a multicenter, prospective study
    Ganschow, Rainer
    Ericzon, Bo-Goran
    Dhawan, Anil
    Sharif, Khalid
    Martzloff, El-Djouher
    Rauer, Barbara
    Ng, Jennifer
    Lopez, Patricia
    PEDIATRIC TRANSPLANTATION, 2017, 21 (07)
  • [49] RENAL FUNCTION IN EVEROLIMUS/ENTERIC-COATED MYCOPHENOLATE SODIUM TREATED DE NOVO LIVING RENAL TRANSPLANT RECIPIENTS AFTER CALCINEURIN INHIBITOR WITHDRAWAL: SUBGROUP ANALYSIS OF THE ZEUS STUDY
    Lehner, F.
    Arns, W.
    Reinke, P.
    Eisenberger, U.
    Paulus, E. -M.
    Scheidl, S.
    Witzke, O.
    Budde, K.
    Sommerer, C.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 50 - 51
  • [50] Everolimus With Reduced Exposure to a Calcineurin Inhibitor in Pediatric Liver Transplant Recipients: Baseline Data From the H2305 Study.
    Ganschow, R.
    Fischer, L.
    Ericzon, B.
    Dhawan, A.
    D'Alessandro, A.
    Goss, J.
    Sips, C.
    Balfour, A.
    Junge, G.
    TRANSPLANTATION, 2014, 98 : 719 - 719
12345